James Ge

JG

Statistics

Publications

1

Citations

35

H-Index

1

Active since

2019

James Ge is an author at Karyopharm Therapeutics (United States) specializing in tyrosine kinase inhibitor therapy, lenvatinib therapy, and tumor progression.

Publications per year

2019–2019

1

Publications

1